Simulect 00078-0331

Generic: Basiliximab

Product NDC

00078-0331

Manufacturer: Novartis Pharmaceuticals Corporation
Dosage Form: Injection, Powder, For Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: May 12, 1998
Listing Expires: December 31, 2026
Application: BLA103764

Need to source Simulect? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Basiliximab	20 mg/5mL

Drug Class

Interleukin-2 Receptor Blocking Antibody [EPC]Interleukin 2 Receptor Antagonists [MoA]Interleukin 2 Receptor-directed Antibody Interactions [MoA]

Packaging Options(1)

00078-0331-84

1 VIAL, SINGLE-USE in 1 CARTON (0078-0331-84) / 5 mL in 1 VIAL, SINGLE-USE

View →